Doravirine Patent Expiration

Doravirine is Used for treating HIV-1 infection in pediatric patients. It was first introduced by Merck Sharp And Dohme Corp A Sub Of Merck And Co Inc in its drug Pifeltro on Aug 30, 2018.

Doravirine Patents

Given below is the list of patents protecting Doravirine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Pifeltro	US8486975	Non-nucleoside reverse transcriptase inhibitors	Aug 30, 2032	Msd Merck Co

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List